Science
Mechanism of Action
Bergenin operates via a triple-action pathway: it inhibits tyrosinase activity to regulate melanin production, acts as a PPAR-γ agonist to modulate inflammatory responses through the Nrf2/NF-κB signaling pathways, and stimulates the synthesis of Collagen I to improve dermal density and elasticity.
Research
Clinical Evidence
High confidence0.7%
Key findings
- 01 Clinical testing of encapsulated delivery systems (1.0%–10.0% raw material concentration) demonstrated measurable reductions in wrinkle depth and significant increases in Type I Collagen synthesis.
- 02 Demonstrated inhibition of pro-inflammatory cytokines including TNF-α and IL-6, reducing cellular oxidative stress and neutrophil migration.
Transparency
Dusting Analysis
Due to its high cost and efficacy at low levels, many formulations include Bergenin at 'label claim' concentrations below 0.1%. At Moumoujus, we consider levels below 0.2% insufficient for achieving the collagen-boosting and brightening results seen in clinical data.
The Formula
Formulation
Stability
Highly sensitive to alkaline conditions; the molecule begins to degrade significantly at a pH of 6.8 or higher. Encapsulation is the preferred delivery method to enhance both aqueous solubility and long-term stability.
Synergies
- Vitamin C
- Niacinamide
- Peptides
Conflicts
- Alkaline ingredients
- Certain Carbomer-based thickeners
Safety
Safety Profile
While pure 100% Bergenin is a potential irritant, it is non-cytotoxic and exceptionally well-tolerated at the precision concentrations (<1%) utilized in topical cosmetic applications.
Your Skin
Skin Compatibility
Our Assessment
Verdict
An exceptional bioactive for sensitive-skin-friendly brightening and structural rejuvenation, provided it is formulated within a strict acidic pH range.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources